|
Volumn 2, Issue 3, 2001, Pages 245-252
|
Chronic myelogenous leukemia in chronic phase.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
IMATINIB;
PIPERAZINE DERIVATIVE;
PROTEIN TYROSINE KINASE;
PYRIMIDINE DERIVATIVE;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
DRUG ANTAGONISM;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MULTIMODALITY CANCER THERAPY;
REVIEW;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
ENZYME INHIBITORS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LEUKEMIA, MYELOID, CHRONIC;
PIPERAZINES;
PROTEIN-TYROSINE KINASES;
PYRIMIDINES;
|
EID: 0035383005
PISSN: 15272729
EISSN: None
Source Type: Journal
DOI: 10.1007/s11864-001-0038-0 Document Type: Review |
Times cited : (7)
|
References (20)
|